MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Higher levels of lactate dehydrogenase (LDH) at baseline were independently linked to an increased risk for heart failure (HF) events or cardiovascular death in patients with HF with reduced ejection ...

Analysis of BRAF mutation status in high-risk malignant melanoma patients having received HD IFNa therapy in adjuvant setting. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Irinotecan liposome combined with anlotinib as second-line treatment in patients with small cell lung cancer (SCLC). Correlation of LDH and α-HBDH with PFS Spearman's correlation-detailed format. PFS ...

Patients relapsing within three months post-CAR T-cell therapy have lower response rates to BsAb therapy compared to those relapsing after six months. Elevated LDH levels and higher international ...